Publications

2024¶

• Protocol of a monocentric, double-blind, randomized, superiority, controlled trial evaluating the effect of in-prison OROS-methylphenidate vs. placebo treatment in detained people with attention-deficit hyperactivity disorder (BATIR)
  Baggio, S. Billieux, J. Dirkzwager, A. Iglesias, K. Moschetti, K. Perroud, N. Schneider, M. Vernaz, N. Wolff, H. Heller, P.
  Trials 2024 DOI: 10.1186/s13063-023-07827-7
• The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study
  Bandiera,Carole Dotta-Celio,Jennifer Locatelli,Isabella Nobre,Dina Wuerzner,Grégoire Pruijm,Menno Lamine,Faiza Burnier,Michel Zanchi,Anne Schneider,Marie Paule
  Frontiers in Pharmacology 2024 DOI: 10.3389/fphar.2024.1294436
• [Assisted teleconsultation in an outpatient pharmacy: Results of a pilot study in Geneva, Switzerland](https://doi.org/10.1177/1357633X231223269 https://journals.sagepub.com/doi/10.1177/1357633X231223269)
  Braillard, Olivia Mazouri Karker, Sanae Djarmouni, Rafik Lafaix, Rémi Guessous, Idris Schneider, Marie P.
  Journal of Telemedicine and Telecare 2024 DOI: 10.1177/1357633X231223269
• Patient-Perceived Impact of the COVID-19 Pandemic on Medication Adherence and Access to Care for Long-Term Diseases: A Cross-Sectional Online Survey
  Santos, Beatriz Boulaguiem, Younes Baysson, Helene Pullen, Nick Guessous, Idris Guerrier, Stephane Stringhini, Silvia Schneider, Marie P.
  COVID 2024 DOI:

2023¶

• Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study
  Bandiera, Carole Locatelli, Isabella Courlet, Perrine Cardoso, Evelina Zaman, Khalil Stravodimou, Athina Dolcan, Ana Sarivalasis, Apostolos Zurcher, Jean-Philippe Aedo-Lopez, Veronica Dotta-Celio, Jennifer Peters, Solange Guidi, Monia Wagner, Anna Dorothea Csajka, Chantal Schneider, Marie P.
  Cancers 2023 DOI:
• Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care
  Bawab, Noura Moullin, Joanna Jotterand, Sébastien Rossier, Christophe Schneider, Marie-Paule Perraudin, Clémence
  Journal of Continuing Education in the Health Professions 2023 DOI:
• Perceptions of conflicting information about long-term medications: a qualitative in-depth interview study of patients with chronic diseases in the Swiss ambulatory care system
  Beatriz, Santos Katherine, S. Blondon Marie, Sottas Delesha, Carpenter Claudine, Backes Elisabeth Van, Gessel Marie, P. Schneider
  BMJ Open 2023 DOI: 10.1136/bmjopen-2022-070468
• Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study
  Mena, S. Moullin, J. C. Schneider, M. Niquille, A.
  BMC Geriatr 2023 DOI: 10.1186/s12877-023-04335-w
• Learning motivational interviewing to better support patient medication adherence
  Novais, T. Fortini, C. Dima, A. L. Schott, A. M. Viprey, M. Schneider, M. P.
  Rev Med Suisse 2023 DOI: 10.53738/revmed.2023.19.823.777
• HIV self-tests in community pharmacies Inventory and practice recommendations for interprofessional collaborations
  Rousseau, M. Solh Dost, S. Santos, B. Gauthier, R. Cavassini, M. Calmy, A. Schneider, M.
  Rev Med Suisse 2023 DOI: 10.53738/revmed.2023.19.847.2017

2022¶

• Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study
  Bandiera, C. Lam, L. Locatelli, I. Dotta-Celio, J. Duarte, D. Wuerzner, G. Pruijm, M. Zanchi, A. Schneider, M. P.
  Diabetol Metab Syndr 2022 DOI: 10.1186/s13098-022-00898-7
• Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis
  Bandiera, C. Pasquier, J. Locatelli, I. Niquille, A. Wuerzner, G. Dotta-Celio, J. Hachfeld, A. Wandeler, G. Wagner, A. D. Csajka, C. Zanchi, A. Cavassini, M. Schneider, M. P.
  Patient Prefer Adherence 2022 DOI: 10.2147/ppa.S377780
• Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action
  Bandiera,Carole Ribaut,Janette Dima,Alexandra L. Allemann,Samuel S. Molesworth,Kate Kalumiya,Kabeza Käser,Fabian Olson,Melvin Skip Burnier,Michel van Boven,Job F. M. Szucs,Thomas Albrecht,Daniel Wilson,Ira De Geest,Sabina Schneider,Marie P.
  International Journal of Public Health 2022 DOI: 10.3389/ijph.2022.1605204
• Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland
  Bandiera, Carole Skrabal Ross, Xiomara Cardoso, Evelina Wagner, Dorothea Csajka, Chantal Olver, Ian Patterson, Pandora Suppiah, Vijayaprakash Gunn, Kate M. Schneider, Marie
  Supportive Care in Cancer 2022 DOI: 10.1007/s00520-021-06710-y
• Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes
  Bawab, Noura Schneider, Marie-Paule Ballabeni, Pierluigi Locatelli, Isabella Bugnon, Olivier Perraudin, Clémence
  Diabetes Spectrum 2022 DOI: 10.2337/ds21-0084
• Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer
  Courlet, Perrine Cardoso, Evelina Bandiera, Carole Stravodimou, Athina Zurcher, Jean-Philippe Chtioui, Haithem Locatelli, Isabella Decosterd, Laurent Arthur Darnaud, Léa Blanchet, Benoit Alexandre, Jérôme Wagner, Anna Dorothea Zaman, Khalil Schneider, Marie Paule Guidi, Monia Csajka, Chantal
  Pharmaceutics 2022 DOI:
• Reimbursed medication adherence enhancing interventions in 12 european countries: Current state of the art and future challenges
  Kardas,Przemysław Bago,Martina Barnestein-Fonseca,Pilar Garuolienė,Kristina Granas,Anne Gerd Gregório,João Hadžiabdić,Maja Ortner Kostalova,Barbora Leiva-Fernández,Francisca Lewek,Pawel Mala-Ladova,Katerina Schneider,Marie Paule van Boven,Job F. M. Volmer,Daisy Ziampara,Ioli Ágh,Tamás
  Frontiers in Pharmacology 2022 DOI: 10.3389/fphar.2022.944829
• Motivational interviewing to support medication adherence in adults with chronic conditions: Systematic review of randomized controlled trials
  Papus, M. Dima, A. L. Viprey, M. Schott, A. M. Schneider, M. P. Novais, T.
  Patient Educ Couns 2022 DOI: 10.1016/j.pec.2022.06.013
• Estimation of adherence to medication treatment in presence of censoring
  Pasquier, J. Schneider, M. P. Locatelli, I.
  Br J Clin Pharmacol 2022 DOI: 10.1111/bcp.15452
• Patients’ perceptions of conflicting information on chronic medications: a prospective survey in Switzerland
  Santos, Beatriz Blondon, Katherine S Van Gessel, Elisabeth Cerutti, Bernard Backes, Claudine Locher, Sophie Guignard, Bertrand Bonnabry, Pascal Carpenter, Delesha Schneider, Marie P
  BMJ Open 2022 DOI: 10.1136/bmjopen-2021-060083
• Partnership between patients and interprofessional healthcare providers along the multifaceted journey to medication adherence
  Schneider, M. P. Burnier, M.
  Br J Clin Pharmacol 2022 DOI: 10.1111/bcp.15325

2021¶

• Digital Medication Adherence Support: Could Healthcare Providers Recommend Mobile Health Apps?
  Backes,Claudine Moyano,Carla Rimaud,Camille Bienvenu,Christine Schneider,Marie P.
  Frontiers in Medical Technology 2021 DOI: 10.3389/fmedt.2020.616242
• Optimizing Oral Targeted Anticancer Therapies Study for Patients With Solid Cancer: Protocol for a Randomized Controlled Medication Adherence Program Along With Systematic Collection and Modeling of Pharmacokinetic and Pharmacodynamic Data
  Bandiera, C. Cardoso, E. Locatelli, I. Digklia, A. Zaman, K. Diciolla, A. Cristina, V. Stravodimou, A. Veronica, A. L. Dolcan, A. Sarivalasis, A. Liapi, A. Bouchaab, H. Orcurto, A. Dotta-Celio, J. Peters, S. Decosterd, L. Widmer, N. Wagner, D. Csajka, C. Schneider, M. P.
  JMIR Res Protoc 2021 DOI: 10.2196/30090
• Interprofessional Medication Adherence Program for Patients With Diabetic Kidney Disease: Protocol for a Randomized Controlled and Qualitative Study (PANDIA-IRIS)
  Bandiera, C. Dotta-Celio, J. Locatelli, I. Nobre, D. Wuerzner, G. Pruijm, M. Lamine, F. Burnier, M. Zanchi, A. Schneider, M. P.
  JMIR Res Protoc 2021 DOI: 10.2196/25966
• Hospital to home transition of care: challenges for patients with type 2 diabetes
  Boden, L. Castellsague, M. Perrenoud, L. Cimarelli, G. Schneider, M. P. Gastaldi, G.
  Rev Med Suisse 2021 DOI:
• Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study
  Bourdin, A. Schneider, M. P. Locatelli, I. Schluep, M. Bugnon, O. Berger, J.
  Sci Rep 2021 DOI: 10.1038/s41598-021-83220-1
• Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study
  Castillo-Mancilla, Jose R Cavassini, Matthias Schneider, Marie Paule Furrer, Hansjakob Calmy, Alexandra Battegay, Manuel Scanferla, Giulia Bernasconi, Enos Günthard, Huldrych F Glass, Tracy R Swiss HIV Cohort Study
  Open Forum Infectious Diseases 2021 DOI: 10.1093/ofid/ofab032
• Rivaroxaban and medication adherence – A cohort study (RIVA): Qualitative results
  Dotta-Celio, Jennifer Alatri, Adriano Salvi, Monique Mazzolai, Lucia Schneider, Marie Paule
  Thrombosis Update 2021 DOI: https://doi.org/10.1016/j.tru.2021.100057
• Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication
  Parienti, J. J. Fournier, A. L. Cotte, L. Schneider, M. P. Etienne, M. Unal, G. Perré, P. Dutheil, J. J. Morilland-Lecoq, E. Chaillot, F. Bangsberg, D. R. Gagneux-Brunon, A. Prazuck, T. Cavassini, M. Verdon, R. Hocqueloux, L.
  Open Forum Infect Dis 2021 DOI: 10.1093/ofid/ofab316

2020¶

• Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical Review
  Cardoso, E. Guidi, M. Blanchet, B. Schneider, M. P. Decosterd, L. A. Buclin, T. Csajka, C. Widmer, N.
  Ther Drug Monit 2020 DOI: 10.1097/ftd.0000000000000699
• Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients
  Cardoso, E Guidi, M. Khoudour, N. Boudou-Rouquette, P Fabre, E. Tlemsani, C. Arrondeau, J. Goldwasser, F Vidal, M. Schneider, M. P. Wagner, A. D. Widmer, N. Blanchet, B. Csajka, C.
  Clin Ther 2020 DOI: 10.1016/j.clinthera.2020.05.008
• The ABC taxonomy for medication adherence translated into French and German
  Haag, M. Lehmann, A. Hersberger, K. E. Schneider, M. P. Gauchet, A. Vrijens, B. Arnet, I. Allenet, B.
  Br J Clin Pharmacol 2020 DOI: 10.1111/bcp.14172
• An Adherence-Enhancing Program Increases Retention in Care in the Swiss HIV Cohort
  Kamal, S. Glass, T. R. Doco-Lecompte, T. Locher, S. Bugnon, O. Parienti, J. J. Cavassini, M. Schneider, M. P.
  Open Forum Infect Dis 2020 DOI: 10.1093/ofid/ofaa323
• Random forest machine learning algorithm predicts virologic outcomes among HIV infected adults in Lausanne, Switzerland using electronically monitored combined antiretroviral treatment adherence
  Kamal, S. Urata, J. Cavassini, M. Liu, H. Kuoyos, R. Bugnon, O. Wang, W. Schneider, M. P.
  AIDS Care 2020 DOI: 10.1080/09540121.2020.1751045
• Medication adherence and physician-pharmacist collaboration. Focus on the patient with diabetic nephropathy
  Schneider, M. Bandiera, C. Dotta-Celio, J. Zanchi, A.
  Rev Med Suisse 2020 DOI:

2019¶

• Patient adherence to rivaroxaban in deep vein thrombosis, a cohort study in Switzerland: quantitative results
  Dotta-Celio, J. Alatri, A. Locatelli, I. Salvi, M. Bugnon, O. Schneider, M. P. Mazzolai, L.
  Int J Clin Pharm 2019 DOI: 10.1007/s11096-019-00928-x
• Medication adherence : the weakest link in blood pressure control
  Gonzalez, A. Pechere-Bertschi, A. Burnier, M. Schneider, M.
  Rev Med Suisse 2019 DOI:
• Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?
  Perraudin, C. Locca, J. F. Rossier, C. Bugnon, O. Schneider, M. P.
  BMC Health Serv Res 2019 DOI: 10.1186/s12913-018-3851-x
• Adhésion médicamenteuse: Quelles applications payantes peut-on recommander ?
  Rimaud,C; Backes, C; Jeannot, J.G; Schneider, M.P.
  pharmaJournal 2019 DOI:
• A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments
  Schneider, M. P. Achtari Jeanneret, L. Chevaux, B. Backes, C. Wagner, A. D. Bugnon, O. Luthi, F. Locatelli, I.
  Front Pharmacol 2019 DOI: 10.3389/fphar.2018.01567
• Sustainable drug prescription: shared perspectives between physicians and pharmacists
  Schneider, M. P. Sommer, J. Senn, N.
  Rev Med Suisse 2019 DOI:
• Adherence to intermittent preventive treatment for malaria in Papua New Guinean infants: A pharmacological study alongside the randomized controlled trial
  Sottas, O. Guidi, M. Thieffry, B. Schneider, M. Decosterd, L. Mueller, I. Genton, B. Csajka, C. Senn, N.
  PLoS One 2019 DOI: 10.1371/journal.pone.0210789

2018¶

• Assessment of medication adherence and responsible use of isotretinoin and contraception through Belgian community pharmacies by using pharmacy refill data
  Biset, N. Lelubre, M. Senterre, C. Amighi, K. Bugnon, O. Schneider, M. P. De Vriese, C.
  Patient Prefer Adherence 2018 DOI: 10.2147/ppa.S149355
• Effect of Adherence on Pharmacokinetic/Pharmacodynamic Relationships of Oral Targeted Anticancer Drugs
  Cardoso, E. Csajka, C. Schneider, M. P. Widmer, N.
  Clin Pharmacokinet 2018 DOI: 10.1007/s40262-017-0571-z
• Pharmacist-nurse collaborations in medication adherence-enhancing interventions: A review
  Celio, Jennifer Ninane, Françoise Bugnon, Olivier Schneider, Marie Paule
  Patient Education and Counseling 2018 DOI: https://doi.org/10.1016/j.pec.2018.01.022
• HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy
  Kamal, S. Bugnon, O. Cavassini, M. Schneider, M. P.
  HIV Med 2018 DOI: 10.1111/hiv.12542
• Content analysis of antiretroviral adherence enhancing interview reports
  Kamal, Susan Nulty, Paul Bugnon, Olivier Cavassini, Matthias Schneider, Marie P.
  Patient Education and Counseling 2018 DOI: https://doi.org/10.1016/j.pec.2018.05.013
• Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results
  Lelubre, M. Clerc, O. Grosjean, M. Amighi, K. De Vriese, C. Bugnon, O. Schneider, M. P.
  BMC Health Serv Res 2018 DOI: 10.1186/s12913-018-3641-5
• Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy
  Lelubre, M. Clerc, O. Grosjean, M. Amighi, K. De Vriese, C. Bugnon, O. Schneider, M. P.
  BMC Health Serv Res 2018 DOI: 10.1186/s12913-018-3509-8
• Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium
  Lelubre, M. Hamdani, J. Senterre, C. Amighi, K. Peres, M. Schneider, M. P. Bugnon, O. De Vriese, C.
  Pharmacoepidemiol Drug Saf 2018 DOI: 10.1002/pds.4441
• Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance
  Lodi, S. Gunthard, H. F. Dunn, D. Garcia, F. Logan, R. Jose, S. Bucher, H. C. Scherrer, A. U. Schneider, M. P. Egger, M. Glass, T. R. Reiss, P. van Sighem, A. Boender, T. S. Phillips, A. N. Porter, K. Hawkins, D. Moreno, S. Monge, S. Paraskevis, D. Simeon, M. Vourli, G. Sabin, C. Hernan, M. A.
  Aids 2018 DOI: 10.1097/qad.0000000000001692
• Role of the pharmacist in supporting adherence
  Schneider, M.P Aslani, P
  Drug Adherence in Hypertension and Cardiovascular Protection, Updates in Hypertension and Cardiovascular Protection. 2018 DOI: doi.org/10.1007/978-3-319-76593-8

2017¶

• La dimension expérientielle des médicaments antirétroviraux dans les traitements du VIH
  Genre, N. Schneider, M. P. Panese, F.
  Rev Med Suisse 2017 DOI:
• The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
  Kamal, S. Locatelli, I. Wandeler, G. Sehhat, A. Bugnon, O. Metral, M. Du Pasquier, R. Gutbrod, K. Cavassini, M. Schneider, M. P.
  Open Forum Infect Dis 2017 DOI: 10.1093/ofid/ofx070
• Pharmacovigilance and patient adherence
  Olsson, S Schneider, M.P Darko, D.M.
  2017 DOI:

2016¶

• Adherence to statins: updates and practical proposals
  Bauwens, M. Schneider, M. P. Nanchen, D.
  Rev Med Suisse 2016 DOI:
• [Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study](https://www.ingentaconnect.com/content/wk/tdm/2016/00000038/00000004/art00012;jsessionid=a1b6b5qu7g81t.x-ic-live-02 https://www.ingentaconnect.com/content/wk/tdm/2016/00000038/00000004/art00012;jsessionid=17b51e12yxlo1.x-ic-live-03)
  Fuchs, A. Rotzinger, A. Cavassini, M. Bugnon, O. Buclin, T. Schneider, M. P. Csajka, C.
  Ther Drug Monit 2016 DOI: 10.1097/ftd.0000000000000297
• Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?
  Michaud, L. Ludwig, G. Berney, S. Rodrigues, S. Niquille, A. Santschi, V. Favre, A. S. Lange, A. C. Michels, A. A. Vrijens, B. Bugnon, O. Pilon, N. Pascual, M. Venetz, J. P. Stiefel, F. Schneider, M. P.
  Pharm Pract (Granada) 2016 DOI: 10.18549/PharmPract.2016.04.822
• [Development of an algorithm for analysing the electronic measurement of medication adherence in routine HIV care](https://link.springer.com/article/10.1007/s11096-016-0354-x https://link.springer.com/content/pdf/10.1007/s11096-016-0354-x.pdf)
  Rotzinger, A. Cavassini, M. Bugnon, O. Schneider, M. P.
  Int J Clin Pharm 2016 DOI: 10.1007/s11096-016-0354-x
• Switching from a two-tablet regimen of tenofovir/emtricitabine and efavirenz to a one-tablet regimen may affect patients' perceptions and drug management
  Rotzinger, A. Locatelli, I. Bugnon, O. Fayet Mello, A. Parienti, J. J. Cavassini, M. Schneider, M. P.
  HIV Med 2016 DOI: 10.1111/hiv.12345
• Association of disclosure of HIV status with medication adherence
  Rotzinger, A. Locatelli, I. Reymermier, M. Amico, S. Bugnon, O. Cavassini, M. Schneider, M. P.
  Patient Educ Couns 2016 DOI: 10.1016/j.pec.2016.03.012
• Interventions to improve adherence to drug treatment
  Schneider, M.P van Camp, Y Celio, J Cavassini, M
  Drug Utilization Research 2016 DOI: 10.1002/9781118949740.ch37

2015¶

• Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality
  Glass, T. R. Sterne, J. A. Schneider, M. P. De Geest, S. Nicca, D. Furrer, H. Gunthard, H. F. Bernasconi, E. Calmy, A. Rickenbach, M. Battegay, M. Bucher, H. C.
  Aids 2015 DOI: 10.1097/qad.0000000000000782
• Interdisciplinary Medication Adherence Program: The Example of a University Community Pharmacy in Switzerland
  Lelubre, M. Kamal, S. Genre, N. Celio, J. Gorgerat, S. Hugentobler Hampai, D. Bourdin, A. Berger, J. Bugnon, O. Schneider, M.
  Biomed Res Int 2015 DOI: 10.1155/2015/103546

2014¶

• Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme
  Krummenacher, I. Spencer, B. Du Pasquier, S. Bugnon, O. Cavassini, M. Schneider, M. P.
  Int J Clin Pharm 2014 DOI: 10.1007/s11096-014-9930-0
• Assessing medication adherence: options to consider
  Lehmann, A. Aslani, P. Ahmed, R. Celio, J. Gauchet, A. Bedouch, P. Bugnon, O. Allenet, B. Schneider, M. P.
  Int J Clin Pharm 2014 DOI: 10.1007/s11096-013-9865-x

2013¶

• Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study
  Gertsch, A. Michel, O. Locatelli, I. Bugnon, O. Rickenbach, M. Cavassini, M. Schneider, M. P.
  AIDS Patient Care STDS 2013 DOI: 10.1089/apc.2013.0005
• Ultra-adherence with Electronic Pills-box may Reveal Poor Adherence
  Schneider, M; Cavassini, M; Bugnon, O; Senn, N
  J Gen Pract 2013 DOI: 10.4172/2329-9126.1000127

2012¶

• Characteristics of HIV patients referred to a medication adherence program in Switzerland
  Krummenacher, I. Cavassini, M. Bugnon, O. Schneider, M. P.
  Int J Clin Pharm 2012 DOI: 10.1007/s11096-012-9638-y

2011¶

• An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring
  Krummenacher, I. Cavassini, M. Bugnon, O. Schneider, M. P.
  AIDS Care 2011 DOI: 10.1080/09540121.2010.525613

2010¶

• Antiretroviral adherence program in HIV patients: a feasibility study in the Swiss HIV Cohort Study
  Krummenacher, I. Cavassini, M. Bugnon, O. Spirig, R. Schneider, M. P.
  Pharm World Sci 2010 DOI: 10.1007/s11096-010-9437-2
• More HIV-positive women are referred to a medication adherence clinic than men
  Schneider, M. P. Krummenacher, I. Bugnon, O. Cavassini, M.
  Rev Med Suisse 2010 DOI:

2009¶

• Adherence: a review of education, research, practice and policy in Switzerland
  Schneider, M. P. Krummenacher, I. Figueiredo, H. Marquis, J. Bugnon, O.
  Pharm Pract (Granada) 2009 DOI: 10.4321/s1886-36552009000200001

2001¶

• Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions
  Burnier, M. Schneider, M. P. Chiolero, A. Stubi, C. L. Brunner, H. R.
  J Hypertens 2001 DOI: